Headshot of Letisha R. Wyatt.

Letisha R. Wyatt

Associate professor of neurology
Oregon Health and Science University

Letisha R. Wyatt, is associate professor of neurology at Oregon Health and Science University. She earned her Ph.D. in molecular pharmacology and toxicology from the University of Southern California in 2013. Her graduate and postdoctoral research focused on purinergic signaling in the central nervous system as a molecular target for new treatments for alcoholism and stroke.

Wyatt is a former National Institutes of Health predoctoral fellow and has a strong record of mentorship in the laboratory and classroom. She has held prior faculty appointments in the OHSU Library and the Cancer Early Detection Advanced Research Center (CEDAR), working together with researchers to support open-science practices and data stewardship needs. Wyatt also oversees the development and implementation of training programs for scientists from historically minoritized groups and serves as director of innovative policy at the Racial Equity and Inclusion Center. Read more about Wyatt on her personal website, and view her work on ORCID.

Explore more from The Transmitter

Grid of human brain scans.

Dose, scan, repeat: Tracking the neurological effects of oral contraceptives

We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.

By Carina Heller
20 January 2025 | 7 min read
Colorful illustration of a latticework of proteins.

Cracking the code of the extracellular matrix

Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.

By Anna Victoria Molofsky
17 January 2025 | 5 min read
A repeated DNA strand extends farther from the left side of the image with each iteration.

Huntington’s disease gene variants past a certain size poison select cells

The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.

By Angie Voyles Askham
16 January 2025 | 6 min read